Bain Capital Life Sciences Investors, LLC
โขCIK: 1703031โขFiling: Q4 2025
Bain Capital Life Sciences Investors, LLC manages $1.3B across a focused portfolio of 19 holdings within the life sciences sector. The fund exhibits significant conviction in select names, with its top three positions comprising HTFL at $362.9M, VYLD at $256.3M, and OLMA at $212.7M. These concentrated allocations underscore a deep, research-driven approach targeting high-potential opportunities across the life sciences value chain. The current top 10 holdings represent substantial, actionable exposure to key growth vectors within the industry.
Total AUM
$1.3B
QoQ Performance
-13.3%
Positions
18
Top 10 Concentration
91.0%
Latest Filing
Q4 2025
Top Holdings Allocation
HTFL
NAMS
OLMA
YB4P
PHAR
HTFL27.8%
NAMS19.6%
OLMA16.3%
YB4P8.1%
PHARVARIS6.0%
SLDB3.4%
UPB2.8%
XFOR2.4%
๐ Biggest Buys
๐ Biggest Sells
Sector Breakdown
Other100.0%
๐ช Exited Positionssold since Q3 2025
Changes from Q3 2025
โ4 increased
โ7 decreased
Historical Filings
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023